{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:42:56Z","timestamp":1792658576242,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19ek0210094h0003"],"award-info":[{"award-number":["19ek0210094h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.trsl.2021.05.008","type":"journal-article","created":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T21:27:35Z","timestamp":1622928455000},"page":"31-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["MicroRNA Expression Profiling in Diabetic Kidney Disease"],"prefix":"10.1016","volume":"237","author":[{"given":"Hiroki","family":"Ishii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Yanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Aomatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Ookawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2021.05.008_bib0001","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMe1708949","article-title":"A new chapter for diabetic kidney disease","volume":"377","author":"de Boer","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2021.05.008_bib0002","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2337\/diacare.29.01.06.dc05-1063","article-title":"Increased urinary excretions of immunoglobulin g, ceruloplasmin, and transferrin predict development of microalbuminuria in patients with type 2 diabetes","volume":"29","author":"Narita","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.trsl.2021.05.008_bib0003","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.2011060627","article-title":"Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes","volume":"23","author":"Niewczas","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2021.05.008_bib0004","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2337\/dc17-2392","article-title":"Higher collagen vi formation is associated with all-cause mortality in patients with type 2 diabetes and microalbuminuria","volume":"41","author":"Rasmussen","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.trsl.2021.05.008_bib0005","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/10408363.2017.1377682","article-title":"Biomarkers of diabetic nephropathy: A 2017 update","volume":"54","author":"Papadopoulou-Marketou","year":"2017","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.trsl.2021.05.008_bib0006","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1096\/fba.2018-00064","article-title":"MicroRNA as novel biomarkers and therapeutic targets in diabetic kidney disease: An update","volume":"1","author":"Cao","year":"2019","journal-title":"FASEB bioAdvances"},{"key":"10.1016\/j.trsl.2021.05.008_bib0007","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.phrs.2019.01.043","article-title":"Diabetic nephropathy: The regulatory interplay between epigenetics and microRNAs","volume":"141","author":"Sankrityayan","year":"2019","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.trsl.2021.05.008_bib0008","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2021.05.008_bib0009","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2021.05.008_bib0010","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1056\/NEJMoa1616011","article-title":"Liraglutide and Renal Outcomes in Type 2 Diabetes","volume":"377","author":"Mann","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2021.05.008_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2019.10.002","article-title":"Circulating miRNA analysis for cancer diagnostics and therapy","volume":"72","author":"Valihrach","year":"2020","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.trsl.2021.05.008_bib0012","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.tips.2019.09.007","article-title":"miRNAs as Therapeutic Targets in Inflammatory Disease","volume":"40","author":"Lu","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.trsl.2021.05.008_bib0013","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nrm2632","article-title":"Biogenesis of small RNAs in animals","volume":"10","author":"Kim","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.trsl.2021.05.008_bib0014","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrg1379","article-title":"MicroRNAs: small RNAs with a big role in gene regulation","volume":"5","author":"He","year":"2004","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.trsl.2021.05.008_bib0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res"},{"key":"10.1016\/j.trsl.2021.05.008_bib0016","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bcp.2018.06.017","article-title":"MicroRNA: A new generation therapeutic target in diabetic nephropathy","volume":"155","author":"Dewanjee","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.trsl.2021.05.008_bib0017","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s40620-018-0511-5","article-title":"Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies","volume":"31","author":"Gholaminejad","year":"2018","journal-title":"J Nephrol"},{"key":"10.1016\/j.trsl.2021.05.008_bib0018","doi-asserted-by":"crossref","unstructured":"Hesketh EE, Czopek A, Clay M, et al. Renal ischaemia reperfusion injury: a mouse model of injury and regeneration. J visual exp : JoVE. 2014.","DOI":"10.3791\/51816-v"},{"key":"10.1016\/j.trsl.2021.05.008_bib0019","doi-asserted-by":"crossref","unstructured":"Hesketh EE, Vernon MA, Ding P, et al. A murine model of irreversible and reversible unilateral ureteric obstruction. J visual exp : JoVE. 2014.","DOI":"10.3791\/52559"},{"key":"10.1016\/j.trsl.2021.05.008_bib0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0531-5565(96)00036-8","article-title":"Senescence-accelerated mouse (SAM): a novel murine model of senescence","volume":"32","author":"Takeda","year":"1997","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.trsl.2021.05.008_bib0021","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1053\/j.ajkd.2015.08.010","article-title":"AJKD atlas of renal pathology: diabetic nephropathy","volume":"66","author":"Najafian","year":"2015","journal-title":"Am J kidney"},{"key":"10.1016\/j.trsl.2021.05.008_bib0022","doi-asserted-by":"crossref","unstructured":"Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care. 2020;43:S14-s31.","DOI":"10.2337\/dc20-S002"},{"key":"10.1016\/j.trsl.2021.05.008_bib0023","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. modification of diet in renal disease study group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.trsl.2021.05.008_bib0024","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10157-006-0453-4","article-title":"Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease","volume":"11","author":"Imai","year":"2007","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.trsl.2021.05.008_bib0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.trsl.2015.10.009","article-title":"MicroRNA expression profiling in peritoneal fibrosis","volume":"169","author":"Morishita","year":"2016","journal-title":"Trans res"},{"key":"10.1016\/j.trsl.2021.05.008_bib0026","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/srep01555","article-title":"Circulating miRNA profile in HCV infected serum: novel insight into pathogenesis","volume":"3","author":"Shwetha","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2021.05.008_bib0027","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.2147\/IJN.S82587","article-title":"Delivery of microRNA-146a with polyethylenimine nanoparticles inhibits renal fibrosis in vivo","volume":"10","author":"Morishita","year":"2015","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.trsl.2021.05.008_bib0028","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nmeth843","article-title":"In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes","volume":"3","author":"Kloosterman","year":"2006","journal-title":"Nat Methods"},{"key":"10.1016\/j.trsl.2021.05.008_bib0029","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.mce.2018.06.005","article-title":"MicroRNAs and diabetic kidney disease: Systematic review and bioinformatic analysis","volume":"477","author":"Assmann","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.trsl.2021.05.008_bib0030","first-page":"11","article-title":"MicroRNAs in podocyte injury in diabetic nephropathy","author":"Ishii","year":"2020","journal-title":"Front Genetic"},{"key":"10.1016\/j.trsl.2021.05.008_bib0031","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1681\/ASN.2016121280","article-title":"Tissue-specific microrna expression patterns in four types of kidney disease","volume":"28","author":"Baker","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2021.05.008_bib0032","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.gene.2013.06.088","article-title":"A potentially functional polymorphism in the regulatory region of let-7a-2 is associated with an increased risk for diabetic nephropathy","volume":"527","author":"Zhou","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.trsl.2021.05.008_bib0033","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1038\/bjc.2013.552","article-title":"MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis","volume":"109","author":"Silva-Santos","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.trsl.2021.05.008_bib0034","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3233\/CBM-160676","article-title":"Functional analysis of serum microRNAs miR-21 and miR-106a in renal cell carcinoma","volume":"18","author":"Tusong","year":"2017","journal-title":"Cancer biomarker"},{"key":"10.1016\/j.trsl.2021.05.008_bib0035","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1093\/nar\/gkq601","article-title":"Export of microRNAs and microRNA-protective protein by mammalian cells","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.trsl.2021.05.008_bib0036","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11892-019-1156-z","article-title":"Circadian clock genes in Diabetic Kidney Disease (DKD)","volume":"19","author":"Olaoye","year":"2019","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.trsl.2021.05.008_bib0037","doi-asserted-by":"crossref","first-page":"e48652","DOI":"10.1371\/journal.pone.0048652","article-title":"CYP24A1 exacerbated activity during diabetes contributes to kidney tubular apoptosis via caspase-3 increased expression and activation","volume":"7","author":"Tourigny","year":"2012","journal-title":"PLoS One"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524421001377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524421001377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:43:52Z","timestamp":1761828232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524421001377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":37,"alternative-id":["S1931524421001377"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2021.05.008","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA Expression Profiling in Diabetic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2021.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}